Literature DB >> 12131022

Elevated body temperature during myocardial ischemia/reperfusion exacerbates necrosis and worsens no-reflow.

Sharon L Hale1, Robert A Kloner.   

Abstract

PURPOSE: The effects of an elevated body temperature on infarct size were tested in a rabbit model of ischemia/reperfusion.
METHODS: Before coronary artery occlusion, body temperature was raised from baseline at 38.6 +/- 0.1 degrees C to 40.3 +/- 0.2 degrees C in nine treated rabbits. Temperature in eight normothermic rabbits was 38.4 +/- 0.2 degrees C. Both groups received 30 min coronary occlusion and 3 h reperfusion.
RESULTS: In normothermic rabbits, 36 +/- 6% of the ischemic risk region became necrotic but in hyperthermic rabbits myocardial necrosis was significantly increased to 57 +/- 3% of the risk region (P < 0.005) despite similar risk regions and an equal degree of regional myocardial blood flow (RMBF) reduction during ischemia in both groups. Infarct size correlated positively with body temperature (r = 0.66, P < 0.004). RMBF was 43% lower during reperfusion in the previously ischemic areas of hyperthermic hearts compared with the control group (P < 0.04), suggesting worsened no-reflow.
CONCLUSION: Elevation in body temperature by even a few degrees can aggravate necrosis during acute myocardial infarction and worsens no-reflow.

Entities:  

Mesh:

Year:  2002        PMID: 12131022     DOI: 10.1097/00019501-200205000-00007

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  6 in total

1.  Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury.

Authors:  Anne B Lipke; Gustavo Matute-Bello; Raquel Herrero; Venus A Wong; Stephen M Mongovin; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

Review 2.  Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

Review 3.  Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

Review 4.  Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice.

Authors:  Yaniel Castro-Torres; Raimundo Carmona-Puerta; Richard E Katholi
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

Review 5.  Cardiogenic Causes of Fever.

Authors:  Jan Smid; Maximilian Scherner; Oliver Wolfram; Thomas Groscheck; Jens Wippermann; Rüdiger C Braun-Dullaeus
Journal:  Dtsch Arztebl Int       Date:  2018-03-23       Impact factor: 5.594

6.  Response to "Body temperature correlates with mortality in COVID-19 patients".

Authors:  Anne M Drewry; Richard Hotchkiss; Erik Kulstad
Journal:  Crit Care       Date:  2020-07-24       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.